Insulin-Rx
By Adam Lyko
Insulin-Rx is a clinical dose calculator for healthcare professionals, providing basal-bolus insulin titration tools on iOS.
The App DNA
What makes this app unique?
The app removes the cognitive friction of manual titration calculations by providing a slider-based interface for patient weight and insulin data.
For Healthcare professionals who prescribe basal-bolus insulin therapy.
What does it look like?
Key features
Calculates insulin units/kg/day, carbohydrate-to-insulin ratio, correction factors, and bolus doses based on patient weight and total daily insulin.
Replaces manual text input with sliders for patient weight and insulin values to improve input efficiency.
Includes calculators for hemoglobin A1C to average glucose, centimeters to inches, and body mass index.
How much does it cost?
The app is provided as a free utility with no observable monetization or in-app purchase gates.
Velocity
Dormant developmentopaqueShow more...
Insulin-Rx has been inactive for 1704 days, indicating a complete cessation of development. There have been no updates or feature additions in the provided history, and the app remains in a state of long-term stagnation. Given the lack of activity for well over a year, the app is classified as a zombie project.
Who built it?
User Sentiment
What do users think recently?
The recent review mood reads frustrated. Users appreciate clinical utility of the insulin dose calculator allows medical professionals to individualize therapy for patients.
How are ratings & reviews evolving?
What users say, by theme
- Clinical utility of the insulin dose calculator allows medical professionals to individualize therapy for patients
- Users report the app lacks sufficient functionality to justify the cost compared to manual calculations
4 of 4 recent reviews analyzed · limited sample
Read the full review analysisCompetition
Competitive landscape for Insulin-Rx
How's the Medical market?
Insulin-Rx occupies a niche, free-utility position in the Medical category with a 4.67-star rating. The lack of updates since 2022 indicates a stagnant market presence compared to active clinical tools.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Insulin-Rx
Where is it heading?
Users report: The clinical utility market is consolidating around platforms that offer continuous updates and integration with electronic health records. Insulin-Rx is currently exposed to obsolescence, and its lack of maintenance will likely lead to a total loss of user trust.
- The four-year development gap indicates the tool is no longer maintained, which erodes trust for clinical users who require up-to-date medical logic.
The SWOT
- Slider-based input mechanism reduces manual entry friction
- Update clinical logic to match current medical standards
Next best moves
Sunset the application because the development cadence is dormant and clinical standards have evolved → reduce brand risk
The counter-intuitive read
The app's lack of monetization is not a…
Read the full takeBottom line
Insulin-Rx serves a narrow clinical need but its lack of development activity renders it a liability for professional use. Sunset the application to avoid potential risks associated with outdated clinical calculation logic.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated